Online inquiry

IVTScrip™ mRNA-Human ANKRD49, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK19729MR)

This product GTTS-WK19729MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the ANKRD49 protein. This product can be used in Natural killer T (NKT) cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_017704.3
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 54851
UniProt ID Q8WVL7
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD49, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) (GTTS-WK19729MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK15207MR IVTScrip™ mRNA-Human ANKRD20A12P, (Cap 0, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ANKRD20A12P
GTTS-WK22808MR IVTScrip™ mRNA-Human APH1B, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA APH1B
GTTS-WK13927MR IVTScrip™ mRNA-Human ACKR3, (Cap 1, 5-Methyl-CTP, 30 nt-poly(A)) mRNA ACKR3
GTTS-WK25956MR IVTScrip™ mRNA-Human ARMC5, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ARMC5
GTTS-WK16139MR IVTScrip™ mRNA-Human ANKS4B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKS4B
GTTS-WK26630MR IVTScrip™ mRNA-Human ASUN, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ASUN
GTTS-WK26471MR IVTScrip™ mRNA-Human ARFGAP3, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARFGAP3
GTTS-WK8303MR IVTScrip™ mRNA-Human ADAMTS4, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADAMTS4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10AM EDT | May 19, 2026

Register Now →